CXL at the slit lamp uses the same UV irradiation settings and riboflavin concentration as in the operating room, achieving identical results. Patients generally tolerate the procedure well, especially with adjustments for comfort and higher UV intensities that shorten treatment time.
ELZA’s medical director, Prof. Dr. Farhad Hafezi MD, PhD, FARVO, was invited to give two lectures this afternoon at the 18th Annual Meeting of the Moroccan Society of Refractive Surgery and Implantology (SAMIR) in Rabat, Morocco.
ELZA’s research has led to the development of portable corneal cross-linking devices which democratize access to essential eye care, transforming treatment for keratoconus and infectious keratitis in low-to-middle-income countries.
Discover the latest advancements in keratoconus treatment with the ELZA Institute’s innovative techniques: transPRK, PACE, and All Femto-CAIRS, as featured in The Ophthalmologist.
ELZA contributed to the recent 2024 SAoO Annual Congress, held in Lucerne, Switzerland, with Prof. Farhad Hafezi giving multiple lectures and co-leading the Refractive Surgery Course.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
The newspapers Tages-Anzeiger, Der Bund, and Basler Zeitung published a story on laser eye surgery complications, and featured ELZA’s Medical Director, Prof. Farhad Hafezi as the expert contributor to the article.
Prof. Hafezi flew to South Africa to attend OSSA 2024 and give presentations that showcased the latest innovations in corneal cross-linking and biomechanics assessments.
The ELZA Institute’s surgeons and researchers were in Frankfurt this month to present our latest research and results at Winter ESCRS 2024.
Expertscape continuously monitor the research output of all peer-reviewed publication on PubMed and rank the top researchers across all of Medicine. Currently, ELZA has #1, #2 and #5 for corneal cross-linking.
